Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report
CEN Case Reports · 20.07.2026 · 15 (4)
DOI: 10.1007/s13730-026-01164-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift CEN Case Reports, online erschienen am 20.07.2026. Verfasst von Shuma Hirashio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Otake, Hiroshima, 739‑0696, Japan. shuma.hirashio@gmail.com. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Peripheral Blood Stem Cell Transplantation. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
AL amyloidosis is characterized by extracellular deposition of immunoglobulin light-chain fibrils, frequently leading to kidney involvement and progressive organ dysfunction. We report a case of kidney AL amyloidosis secondary to multiple myeloma in which daratumumab-based chemotherapy combined with autologous peripheral blood stem cell transplantation resulted in marked improvement, as confirmed by sequential kidney biopsy. The initial biopsy revealed vascular-dominant amyloid deposition, whereas the second biopsy obtained 2 years later demonstrated a marked reduction in amyloid burden, particularly within the vascular compartments. This histopathological improvement corresponded with hematologic remission and stabilization of kidney function. The observed reduction in tissue amyloid deposits was presumed to result from suppression of amyloidogenic light chains, leading to inhibition of new fibril formation and subsequent tissue remodeling. Our findings provide direct pathological evidence that daratumumab-based combination therapy, through immune-mediated plasma cell depletion, may indirectly promote the regression of amyloid deposits and contribute to functional recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Otake, Hiroshima, 739‑0696, Japan. shuma.hirashio@gmail.com.
- Department of Nephrology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. shuma.hirashio@gmail.com.
- Department of Nephrology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Otake, Hiroshima, 739‑0696, Japan.
- Department of Hematology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Ootake, Hiroshima, 739‑0696, Japan.
- Department of Diagnostic Pathology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Ootake, Hiroshima, 739‑0696, Japan.
- Department of Nephrology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
ORCID-Profile: Shuma Hirashio
Zitieren
APA
Hirashio, S., Ohnari, S., Kadono, M., Shimomura, T., Tachiyama, Y., & Masaki, T. (2026). Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report. CEN Case Reports, 15(4). https://doi.org/10.1007/s13730-026-01164-9
Vancouver
Hirashio S, Ohnari S, Kadono M, Shimomura T, Tachiyama Y, Masaki T. Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report. CEN Case Reports. 2026;15(4). doi:10.1007/s13730-026-01164-9
BibTeX
@article{Hirashio2026,
author = {Hirashio, Shuma and Ohnari, Sayuri and Kadono, Moe and Shimomura, Takeshi and Tachiyama, Yoshiro and Masaki, Takao},
title = {Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report},
journal = {CEN Case Reports},
year = {2026},
volume = {15},
number = {4},
doi = {10.1007/s13730-026-01164-9}
}
EUVIMED